Compare STKL & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STKL | CTKB |
|---|---|---|
| Founded | 1973 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 769.4M | 652.1M |
| IPO Year | 1999 | 2021 |
| Metric | STKL | CTKB |
|---|---|---|
| Price | $6.48 | $4.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $7.83 | $5.63 |
| AVG Volume (30 Days) | ★ 1.9M | 712.1K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 186.67 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $817,715,000.00 | $193,015,000.00 |
| Revenue This Year | $7.74 | $5.42 |
| Revenue Next Year | $32.47 | $7.03 |
| P/E Ratio | $49.77 | ★ N/A |
| Revenue Growth | 12.99 | ★ 17.67 |
| 52 Week Low | $3.32 | $2.37 |
| 52 Week High | $6.94 | $6.18 |
| Indicator | STKL | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 71.46 | 43.25 |
| Support Level | $6.43 | $4.00 |
| Resistance Level | $6.52 | $4.51 |
| Average True Range (ATR) | 0.03 | 0.18 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 64.29 | 39.37 |
SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own proprietary brands, including SOWN, Dream, and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut, and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada, and Others, out of which it derives maximum revenue from U.S.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.